Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Rebecca Zisser/Axios

The first rule of trade negotiations is that they take place in private. The minute either side starts setting out goals and demands in public, positions become hardened and compromise becomes an embarrassing climbdown.

Why it matters: With the imposition of massive new tariffs this week, accompanied by explicit threats, Trump has taken Sino-American trade negotiations outdoors, into a public arena where they have much less chance of success. Even before announcing retaliatory countermeasures, China has similarly gone public with its own red lines. Resolving this dispute is not yet impossible, but it has become exponentially harder. Among the dangers:

  • Recession: Bank of America is already warning that "a trade war could cause a global recession." As Axios' Dion Rabouin has written, this is a war the world cannot afford.
  • Inflation: American tariffs on Chinese goods will increase the price of those goods. If that ends up contributing to domestic inflation, Trump's desire for a rate cut will look even less realistic.
  • Food dumping: As the FT's Alan Beattie notes, Trump has already started talking about using the tariffs as an excuse to dump America's agricultural surplus onto poor countries, undercutting their domestic markets.

The big picture: "When you have both sides convinced that they have the upper hand, you get the kind of conflict that you have right now," China trade expert Patrick Chovanec told Foreign Policy. He added:

"If we want China to embrace structural reform, that requires real commitment—it’s not something we can just twist their arm to do, they have to buy into it. And they have to believe that it is not going to sink them or hurt them. When you basically strongarm them into doing something they really don’t want to do, and they’re convinced it’s harmful to their interests, at some point they are going to cheat, push back, or scuttle it, and it’s just a question of when."

The bottom line: Trump's trade negotiator, Robert Lighthizer, might consider these tariffs to be a tough way of forcing China to make concessions. And the market seems hopeful that the trade war will be temporary, on the grounds that ending it would be rational for both sides. But Trump himself wanted these tariffs all along.

Go deeper: Farmers across the Midwest struggle to cope with Trump's trade war

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities tied to Iranian-backed militia groups in Syria was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

2 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios